Articles Tagged With:
-
Threat of Reinfection Includes Long COVID
Accumulating research suggests reinfections with SARS-CoV-2 increase the likelihood of developing long COVID, the horrific post-acute syndrome with indefinite duration and a panoply of neurological, autoimmune, and physical conditions. Moreover, the risk of developing long COVID incrementally increases with each reinfection, according to a study that found this cumulative effect continues in up to three reinfections.
-
Return to Light Duty Is Key to Full-Time Work
Healthcare workers’ physical injuries account for almost 50% of all injuries reported nationally. The proverbial insult that follows is that the longer they miss work, the less likely they are to return at all. At six months, there is less than a 50% chance they will return. The key justification for returning injured employees to light duty is that it is significantly associated with a return to full-time work and can positively re-engage workers.
-
Wounded Healers: Long COVID Community Helps Its Own
Despite her limitations, Karyn Bishof, MS, founded the COVID-19 Longhauler Advocacy Project and began distributing information to others. Hospital Employee Heath reached out to Bishof for an interview.
-
CDC Seeks Clarity on Masks, Respirators
An advisory panel to the Centers for Disease Control and Prevention recently completed draft isolation guidelines for respiratory patients, but got a thumbs down and a loaded question for their trouble: “Should N95 respirators be recommended for all pathogens that spread by the air?”
-
ICU Delirium Linked to Post-Discharge Change in Cancer Treatment and Higher Mortality Among Cancer Patients
In this single-center, retrospective cohort study, intensive care unit (ICU) delirium was associated with a higher rate of cancer treatment modification, only partly due to worsening performance status, after discharge and higher one-year mortality.
-
Does Alkaline Phosphatase Reduce Sepsis-Associated Acute Kidney Injury?
This Phase III, international, multicenter, double-blind, randomized controlled trial did not show a reduction in 28-day all-cause mortality with ilofotase alfa (recombinant human alkaline phosphatase). However, the study showed evidence to suggest that ilofotase alfa reduced major adverse kidney events at 90 days, mainly driven by lowering the incidence of renal replacement therapy through day 90 in these patients.
-
Ventilation and Oxygenation Considerations During and After Cardiopulmonary Resuscitation
With a multitude of recommendations spanning from monitoring during cardiopulmonary resuscitation (CPR) to post-arrest targeted temperature management, the specific focus of this article is to review considerations related to ventilation and oxygenation during and after CPR.
-
Effect of Atrial Fibrillation Catheter Ablation on Psychological Well-Being
A randomized trial of catheter ablation vs. medical therapy for atrial fibrillation (AF) patients has shown that anxiety and depression scores are significantly reduced by catheter ablation and are associated with decreases in AF burden and improved physical symptoms.
-
Long-Term Antiplatelet Therapy After PCI
The five-year follow-up of patients randomized to clopidogrel vs. aspirin monotherapy beyond one year after percutaneous coronary intervention has shown that clopidogrel is noninferior, but not superior, to aspirin for preventing the combined endpoint of adverse cardiovascular or major bleeding events.
-
PFO Closure Review Shows High Proportion of Off-Label Use
In this retrospective cohort study using administrative data from a U.S. payor source, only 58.6% of patients undergoing patent foramen ovale closure had the procedure done for the approved indication of stroke or systemic embolism. A significant proportion of patients were outside the recommended age range.